✦ LIBER ✦

300 Sensitivity of NS3 serine proteases from various hepatitis C virus genotypes to the antiviral compound BILN 2061

✍ Scribed by Diane Thibeault; Christiane Bousquet; Rock Gingras; Lisette Lagacé; Roger Maurice; Peter W. White; Daniel Lamarre

Book ID: 119530209
Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 150 KB
Volume: 38
Category: Article
ISSN: 0270-9139
DOI: 10.1016/s0270-9139(03)80343-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antiviral efficacy of NS3-serine proteas

Antiviral efficacy of NS3-serine protease inhibitor BILN-2061 in patients with chronic genotype 2 and 3 hepatitis C

✍ Markus Reiser; Holger Hinrichsen; Yves Benhamou; Henk W. Reesink; Heiner Wedemey 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB

The design of a potent inhibitor of the

The design of a potent inhibitor of the hepatitis C virus NS3 protease: BILN 2061—From the NMR tube to the clinic

✍ Youla S. Tsantrizos 📂 Article 📅 2004 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 858 KB

## Abstract The virally encoded serine protease NS3/NS4A is essential to the life cycle of the hepatitis C virus (HCV), an important human pathogen causing chronic hepatitis, cirrhosis of the liver, and hepatocellular carcinoma. Until very recently, the design of inhibitors for the HCV NS3 protease

Structure−Activity Study on a Novel Seri

Structure−Activity Study on a Novel Series of Macrocyclic Inhibitors of the Hepatitis C Virus NS3 Protease Leading to the Discovery of BILN 2061

✍ Llinàs-Brunet, Montse; Bailey, Murray D.; Bolger, Gordon; Brochu, Christian; Fau 📂 Article 📅 2004 🏛 American Chemical Society 🌐 English ⚖ 77 KB